— Know what they know.
Not Investment Advice

CHALF OTC

Chalice Brands Ltd
1W: +9900.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · $6660 mcap · 64M float · 0.0005% daily turnover

Balance Sheet Trends

Total Assets
$28M -11.2% ▼
5Y CAGR: +25.0%
Total Liabilities
$23M +7.5% ▲
5Y CAGR: +15.4%
Shareholders Equity
$5M -48.4% ▼
Cash & Investments
$905K -74.4% ▼
5Y CAGR: +28.0%
Total Debt
$11M +14.6% ▲
5Y CAGR: +23.9%
Net Debt
$10M +65.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2016FY2017FY2018FY2019FY2020
— Assets —
Cash$4M$6M$12M$4M$905K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$4M$6M$12M$4M$905K
Net Receivables$1M$1M$2M$887K$2M
Inventory$942K$4M$3M$3M$3M
Other Current Assets$3M$653K$2M$325K$0
Total Current Assets$9M$12M$20M$8M$6M
Property, Plant & Equip.$2M$6M$6M$8M$6M
Goodwill & Intangibles$9M$58M$47M$11M$15M
Long-Term Investments$5M$0$0$0$0
Other Non-Current Assets$388K$0$0$919K$657K
Total Non-Current Assets$16M$64M$53M$24M$22M
Total Assets$25M$76M$73M$32M$28M
— Liabilities —
Accounts Payable$2M$3M$3M$2M$3M
Short-Term Debt$13M$793K$9M$926K$7M
Deferred Revenue$188K$49K$431K$0$0
Other Current Liabilities$416K$61K$369K-$1M-$2M
Total Current Liabilities$16M$4M$12M$3M$11M
Long-Term Debt$12M$30M$5M$9M$5M
Other Non-Current Liab.$0$24M$9M$9M$7M
Total Non-Current Liabilities$12M$54M$15M$18M$11M
Total Liabilities$28M$58M$27M$21M$23M
— Equity —
Common Stock$34M$109M$139M$148M$150M
Retained Earnings-$42M-$97M-$101M-$143M-$151M
Accumulated OCI-$530K$10K-$126K$0$0
Total Stockholders Equity-$3M$18M$47M$11M$5M
Total Liabilities & Equity$25M$76M$73M$32M$28M
— Key Metrics —
Total Debt$26M$31M$14M$10M$11M
Net Debt$22M$25M$2M$6M$10M
Total Investments$5M$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms